Grants per year
Personal profile
Education/Academic qualification
Life Sciences, PhD, HBNI University
… → 2016
MA, University of Mumbai, India
… → 2010
Fingerprint
Dive into the research topics where Crismita Clement Dmello is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The immunosuppressive function of Checkpoint kinase 2 in gliomas
Dmello, C. C. (PD/PI), Lee Chang, C. (Co-Investigator) & Wang, L. (Co-Investigator)
National Institute of Neurological Disorders and Stroke
9/19/24 → 8/31/29
Project: Research project
-
Enhancing the responsiveness of gliomas to immunotherapy by pharmacological inhibition of Chek2: Setting the stage for a clinical trial
Dmello, C. C. (PD/PI) & Sonabend Worthalter, A. M. (PD/PI)
U.S. Army Medical Research and Materiel Command
9/15/20 → 9/14/22
Project: Research project
-
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma
Budhiraja, S., McManus, G., Baisiwala, S., Perrault, E. N., Cho, S., Saathoff, M., Chen, L., Park, C. H., Kazi, H. A., Dmello, C., Lin, P., James, C. D., Sonabend, A. M., Heiland, D. H. & Ahmed, A. U., Aug 1 2024, In: Neuro-oncology. 26, 8, p. 1421-1437 17 p.Research output: Contribution to journal › Article › peer-review
-
Combining causal and correlative approaches to discover biomarkers of response to paclitaxel
Moscona-Nissan, A., Habashy, K. J., Arrieta, V. A., Sonabend, A. M. & Dmello, C., 2024, In: Oncotarget. 15, p. 117-122 6 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Arrieta, V. A., Duerinck, J., Burdett, K. B., Habashy, K. J., Geens, W., Gould, A., Schwarze, J. K., Dmello, C., Kim, K. S., Saganty, R., Chen, L., Moscona, A., McCord, M., Lee-Chang, C., Horbinski, C. M., Zhang, H., Stupp, R., Neyns, B. & Sonabend, A. M., Jan 15 2024, In: Clinical Cancer Research. 30, 2, p. 379-388 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
Kim, K. S., Habashy, K., Gould, A., Zhao, J., Najem, H., Amidei, C., Saganty, R., Arrieta, V. A., Dmello, C., Chen, L., Zhang, D. Y., Castro, B., Billingham, L., Levey, D., Huber, O., Marques, M., Savitsky, D. A., Morin, B. M., Muzzio, M. & Canney, M. & 14 others, , Nov 1 2024, In: Neuro-oncology. 26, 11, p. 2044-2060 17 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Rashidi, A., Billingham, L. K., Zolp, A., Chia, T. Y., Silvers, C., Katz, J. L., Park, C. H., Delay, S., Boland, L., Geng, Y., Markwell, S. M., Dmello, C., Arrieta, V. A., Zilinger, K., Jacob, I. M., Lopez-Rosas, A., Hou, D., Castro, B., Steffens, A. M. & McCortney, K. & 14 others, , Jan 2 2024, In: Cell Metabolism. 36, 1, p. 62-77.e8Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations